“Producers have no money to pay the sum charged. We demand that a solution be found to cancel the payment (…) The pharmaceutical industry is obligated to finance a deficit of 1 billion lei (EUR224 million, e.n.),” said Dragos Damian, president of the Association of Romanian Producers of Generic Drugs (APMGR) and CEO of pharmaceutical company Terapia Ranbaxy.

Romanian Association of International Drug Producers representative Sorin Popescu said the sums charged are too high and equal costs of a highway section.

Health Minister Vasile Cepoi said earlier Monday ministry officials are trying to find a way to solve the problems caused by charging the clawback tax to drug producers, a situation that could seriously affect medicine supplies.

Last week, Damian said the clawback tax for the first quarter of 2012 was almost double the tax for the fourth quarter of 2011, which was 17%-20% of the sales of every producer. He warned that enforcing this tax would have very serious economic and social consequences,” eliminating certain drugs from the market and pushing producers of generic drugs into insolvency. (EUR1=RON4.4641)